0001616308-17-000002.txt : 20171107 0001616308-17-000002.hdr.sgml : 20171107 20171107113228 ACCESSION NUMBER: 0001616308-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171107 DATE AS OF CHANGE: 20171107 EFFECTIVENESS DATE: 20171107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reiley Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001616308 IRS NUMBER: 471097516 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-298211 FILM NUMBER: 171182285 BUSINESS ADDRESS: STREET 1: 367 SANTANA HEIGHTS #7007 CITY: SAN JOSE STATE: CA ZIP: 95128 BUSINESS PHONE: 408-718-9027 MAIL ADDRESS: STREET 1: 367 SANTANA HEIGHTS #7007 CITY: SAN JOSE STATE: CA ZIP: 95128 D 1 primary_doc.xml X0708 D LIVE 0001616308 Reiley Pharmaceuticals, Inc. 3749 Buchanan Street Suite 475745 San Francisco CA CALIFORNIA 94147 408-718-9027 DELAWARE None None Corporation true 2014 B Michael Silber 827 Marina San Francisco CA CALIFORNIA 94123 Executive Officer Jeff Dunn 367 Santana Heights #7007 San Jose CA CALIFORNIA 95128 Director Mark Reiley 817 Independence Ave Washington DC DISTRICT OF COLUMBIA 20003 Promoter Pharmaceuticals No Revenues 06b false 2017-11-06 false true false 12500 1200000 1200000 0 false 19 0 0 0 false Reiley Pharmaceuticals, Inc. B. Michael Silber B Michael Silber CEO 2017-11-07